IMA

ImageneBio Inc (IMA) SWOT Analysis Analysis (2026)

Invetso Score: 4.5/10 — Balanced · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Strengths

Score: 4.2 (Moderate)

Negative cash conversion cycle of -485 days indicates suppliers finance working capital, supporting liquidity versus peers with longer cash cycles.

Current and quick ratios above 21x show exceptional short-term solvency, reducing refinancing pressure relative to more levered peers.

Debt-to-equity of 0.01x suggests minimal balance-sheet leverage, leaving more financial flexibility than capital-intensive peers.

ROIC is deeply negative, but the working-capital structure still provides a durable funding advantage versus peers with tighter liquidity.

Weaknesses

Score:

ROIC of -39.8% indicates capital is not earning its cost, leaving the company structurally weaker than profitable peers.

Net debt to EBITDA of 1.76x is manageable, but it still exceeds the near-zero leverage profile of the strongest peers.

Operating and gross margin data are unavailable, limiting evidence of pricing power and making peer margin positioning difficult to support.

The very large negative cash conversion cycle may reflect customer prepayments or inventory timing, but it also signals dependence on working-capital dynamics.

Opportunities

Score:

If the negative cash conversion cycle is sustained, working-capital efficiency can continue to fund growth more cheaply than peers.

Low leverage creates capacity to absorb volatility or finance expansion more flexibly than more indebted competitors.

Improving returns on invested capital would materially narrow the gap to peers because current profitability is the main structural drag.

Additional disclosure on segment mix and margins could clarify whether the business has underappreciated scale or niche advantages versus peers.

Threats

Score:

Persistently negative ROIC threatens long-term value creation and leaves the company vulnerable to peers with stronger capital discipline.

If the cash conversion cycle normalizes, liquidity could tighten quickly because current working-capital benefits are unusually large.

Net debt remains meaningful relative to the near-zero equity leverage profile, so weaker operating performance could pressure flexibility versus peers.

Limited segment and margin disclosure increases uncertainty, which can mask competitive weakness relative to more transparent peers.

Overall Score

Score:

IMA’s structural profile is mixed, with exceptional liquidity and working-capital efficiency offset by deeply negative returns on capital and limited evidence of durable operating strength versus peers.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on ImageneBio Inc. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →